Perilipin-1 Antibody (Rabbit mAb) [B3G1]

CatNo: F2889

    Application: Reactivity:
    • Lane 1: 293T, Lane 2: 293T (hPLIN1 transfected)
    1/

    当該製品は品切れ状态で、メールアドレスをご教示いただければ、お客様に返信いたします。

    代表番号: 045-509-1970|電子メール:sales@selleck.co.jp

    使用情報

    Dilution
    1:1000-1:5000
    1:100-1:250
    Application
    WB, IF
    Source
    Rabbit Monoclonal Antibody
    Reactivity
    Human
    Storage Buffer
    PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
    Storage (from the date of receipt)
    -20°C (avoid freeze-thaw cycles), 2 years
    Predicted MW
    56 kDa
    ポジティブコントロール Fetal heart tissue; Human adipose tissue; Fetal liver tissue; HepG2 cells
    ネガティブコントロール

    プロトコール

    WB
    Experimental Protocol:
     
    Sample preparation
    1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail),and homogenize the tissue at a low temperature or lyse it by sonication on ice, then incubate on ice for 30 minutes.
    2. Adherent cell: Aspirate the culture medium and wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) , sonicate to lyse the cells, and incubate on ice for 30 minutes.
    3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) , sonicate to lyse the cells, and incubate on ice for 30 minutes.
    4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant;
    5. Remove a small volume of lysate to determine the protein concentration;
    6. Combine the lysate with protein loading buffer. Boil 20 µL sample under 95-100°C for 5 min. Centrifuge for 5 min after cool down on ice.
     
    Electrophoretic separation
    1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Recommended separating gel (lower gel) concentration: 10%. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations
    2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
     
    Transfer membrane
    1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
    2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
    3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip";
    4. The protein was electrotransferred to PVDF membrane. ( 0.45 µm PVDF membrane is recommended ) Reference Table for Selecting PVDF Membrane Pore Size Specifications
    Recommended conditions for wet transfer: 200 mA, 120 min.
    ( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
     
    Block
    1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
    2. Incubate the film in the blocking solution for 1 hour at room temperature;
    3. Wash the film with TBST for 3 times, 5 minutes each time.
     
    Antibody incubation
    1. Use primary antibody dilution buffer to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:1000), gently shake and incubate with the film at 4°C overnight;
    2. Wash the film with TBST 3 times, 5 minutes each time;
    3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
    4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
     
    Antibody staining
    1. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
    2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system.
    IF
    Experimental Protocol:
     
    Sample Preparation
    1. Adherent Cells: Place a clean, sterile coverslip in a culture dish. Once the cells grow to near confluence as a monolayer, remove the coverslip for further use.
    2. Suspension Cells: Seed the cells onto a clean, sterile slide coated with poly-L-lysine.
    3. Frozen Sections: Allow the slide to thaw at room temperature. Wash it with pure water or PBS for 2 times, 3 minutes each time.
    4. Paraffin Sections: Deparaffinization and rehydration. Wash the slide with pure water or PBS for 3 times, 3 minutes each time. Then perform antigen retrieval.
     
    Fixation
    1. Fix the cell coverslips/spots or tissue sections at room temperature using a fixative such as 4% paraformaldehyde (4% PFA) for 10-15 minutes.
    2. Wash the sample with PBS for 3 times, 3 minutes each time.
     
    Permeabilization
    1.Add a detergent such as 0.1–0.3% Triton X-100 to the sample and incubate at room temperature for 10–20 minutes.
    (Note: This step is only required for intracellular antigens. For antigens expressed on the cell membrane, this step is unnecessary.)
    Wash the sample with PBS for 3 times, 3 minutes each time.
     
    Blocking
    Add blocking solution and incubate at room temperature for at least 1 hour. (Common blocking solutions include: serum from the same source as the secondary antibody, BSA, or goat serum.)
    Note: Ensure the sample remains moist during and after the blocking step to prevent drying, which can lead to high background.
     
    Immunofluorescence Staining (Day 1)
    1. Remove the blocking solution and add the diluted primary antibody.
    2. Incubate the sample in a humidified chamber at 4°C overnight.
     
    Immunofluorescence Staining (Day 2)
    1. Remove the primary antibody and wash with PBST for 3 times, 5 minutes each time.
    2. Add the diluted fluorescent secondary antibody and incubate in the dark at 4°C for 1–2 hours.
    3. Remove the secondary antibody and wash with PBST for 3 times, 5 minutes each time.
    4. Add diluted DAPI and incubate at room temperature in the dark for 5–10 minutes.
    5. Wash with PBST for 3 times, 5 minutes each time.
     
    Mounting
    1. Mount the sample with an anti-fade mounting medium.
    2. Allow the slide to dry at room temperature overnight in the dark.
    3. Store the slide in a slide storage box at 4°C, protected from light.
     

    Datasheet & SDS

    生物学的記述

    Specificity
    Perilipin-1 Antibody (Rabbit mAb) [B3G1] detects endogenous levels of total Perilipin-1 protein.
    タンパク質の局在
    小胞体、脂質滴
    Uniprot ID
    O60240
    Clone
    B3G1
    Synonym(s)
    PERI, PLIN, PLIN1, Perilipin-1, Lipid droplet-associated protein
    Background
    Perilipin‑1 (PLIN1) is a lipid droplet–associated protein of the perilipin family that localizes to the surface of neutral lipid droplets in adipocytes and other lipid‑storing cells, where it acts as a key determinant of triacylglycerol storage and mobilization within adipose tissue and at lipid–endocrine interfaces. The protein contains central hydrophobic segments that target and anchor it into the phospholipid monolayer of lipid droplets, flanked by regulatory N‑ and C‑terminal regions enriched in consensus motifs for protein kinase A, which provide multiple serine residues that undergo phosphorylation during catecholamine‑driven cAMP signaling. Under basal or fed conditions, nonphosphorylated perilipin‑1 forms a protective coat that shields stored triacylglycerol from access by cytosolic lipases, promoting neutral lipid retention, stabilization of unilocular adipocyte droplets, and maintenance of adipocyte energy stores. Activation of β‑adrenergic receptors and cAMP‑dependent protein kinase leads to multisite phosphorylation of perilipin‑1, a modification that remodels the droplet surface, facilitates redistribution of the lipid droplet population from large perinuclear structures toward dispersed microdroplets, and enables efficient docking and activation of lipolytic machinery. Phosphorylation of defined N‑terminal PKA sites supports hormone‑sensitive lipase access to lipid substrates, whereas phosphorylation at C‑terminal sites contributes to maximal lipolysis, integrating perilipin‑1 into the core of the lipolytic pathway that converts stored triacylglycerol into glycerol and free fatty acids for systemic energy supply. The protein operates within a wider perilipin family context in which multiple splice variants and related paralogues decorate lipid droplets in a cell type–specific fashion, but perilipin‑1 dominates at the adipocyte droplet surface and functions as a principal gatekeeper that determines the balance between lipid storage and catecholamine‑stimulated fatty acid release. Functional analyses summarized in human and mouse work link perilipin‑1–dependent control of lipolysis to overall lipid metabolism, adipocyte size, and circulating lipid profiles, placing PLIN1 at a nodal point for whole‑body energy homeostasis and metabolic flexibility in response to nutritional status. Genetic variants in PLIN1 associate with severe familial partial lipodystrophy, early‑onset acute coronary syndrome, and altered cardiovascular risk, with variant position and type influencing whether the phenotype is characterized by ectopic lipid redistribution, dyslipidemia, or, in some cases, a protective lipid and cardiovascular profile. Perilipin‑1 expression and phosphorylation state also connect adipose lipid handling to atherosclerotic processes, as changes in adipocyte lipolytic output and inflammatory signaling correlate with modifications in vascular lipid deposition and plaque composition. Through its droplet‑anchored structure, PKA‑responsive regulatory motifs, and capacity to gate lipase access and droplet remodeling, perilipin‑1 defines a mechanistic platform that links catecholamine and cAMP signaling to controlled triglyceride hydrolysis and lipid storage.
    References

    技術サポート

    ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。

    Handling Instructions

    他に質問がある場合は、お気軽にお問い合わせください。

    * 必須

    大学・企業名を記入してください
    名前を記入してください
    電子メール・アドレスを記入してください 有効なメールアドレスを入力してください
    お問い合わせ内容をご入力ください